Inhibition of insulin-like growth factor-I receptor (IGF-IR) signaling and tumor cell growth by a fully human neutralizing anti

Inhibition of insulin-like growth factor-I receptor (IGF-IR) signaling and tumor cell growth by a fully human neutralizing anti–IGF-IR antibody

Published:2005-08 Issue:8 Volume:4 Page:1214-1221
ISSN:1535-7163
Container-title:Molecular Cancer Therapeutics
language:en
Short-container-title:Mol Cancer Ther

Author:

Wang Yan,Hailey Judith,Williams Denise,Wang Yaolin,Lipari Philip,Malkowski Michael,Wang Xiaoying,Xie Lei,Li Guanghua,Saha Deba,Ling Wai Lam W.,Cannon-Carlson Susan,Greenberg Robert,Ramos Robert A.,Shields Robert,Presta Leonard,Brams Peter,Bishop W. Robert,Pachter Jonathan A.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 140 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current progress in chimeric antigen receptor-modified T cells for the treatment of metastatic breast cancer;Biomedicine & Pharmacotherapy;2023-06

2. Circulating insulin-like growth factor-1 and risk of lung diseases: A Mendelian randomization analysis;Frontiers in Endocrinology;2023-03-03

3. Results of TRIO-15, a multicenter, open-label, phase II study of the efficacy and safety of ganitumab in patients with recurrent platinum-sensitive ovarian cancer;Gynecologic Oncology;2023-03

4. Mini Review: Molecular Interpretation of the IGF/IGF-1R Axis in Cancer Treatment and Stem Cells-Based Therapy in Regenerative Medicine;International Journal of Molecular Sciences;2022-10-04

5. An overview of resistance to Human epidermal growth factor receptor 2 (Her2) targeted therapies in breast cancer;Cancer Drug Resistance;2022